Diabetes drug may elevate bladder cancer risk

vijigermany

Lord of Penmai
Joined
Jul 5, 2011
Messages
104,204
Likes
20,718
Location
Germany
#1
Diabetes drug may elevate bladder cancer risk

Pioglitazone, a drug commonly prescribed for type 2 diabetes, may also elevate bladder cancer risk, says a new Canadian research.

In a bid to link pioglitazone and bladder cancer, researchers conducted a systematic review and analysis of clinical trials and observational studies involving over 2.6 million patients.

“We observed an increased risk of bladder cancer associated with the use of thiazolidinediones,” writes Jeffrey Johnson from the School of Public Health, University of Alberta and study co-author, the Canadian Medical Association Journal reports.
Thiazolidinediones, including Pioglitazone, introduced in the late 1990s, are also known as glitazones, a class of drugs used in the treatment of type 2 diabetes, according to an Alberta statement.

“In particular, use of pioglitazone was associated with an increased risk of bladder cancer based on a pooled estimate from three cohort studies involving more than 1.7 million individuals,” adds Johnson.

The researchers also looked at a possible association with rosiglitazone, another type of thiazolidinedione, but did not see an effect.
 

Similar threads

Important Announcements!

Type in Tamil

Click here to go to Google transliteration page. Type there in Tamil and copy and paste it.